Abstract
In this issue of Blood, Kridel et al describe recurrent NOTCH1 mutations in mantle cell lymphoma (MCL) by next-generation sequencing of patient samples and cell lines. They further demonstrate a negative prognostic impact of NOTCH1 mutation in their cohort of patients and sensitivity of MCL cells to NOTCH1 inhibition in vitro, suggesting a novel role for NOTCH1 in this disease.
Original language | English |
---|---|
Pages (from-to) | 1957-1958 |
Number of pages | 2 |
Journal | Blood |
Volume | 119 |
Issue number | 9 |
DOIs |
|
State | Published - 1 Mar 2012 |
Externally published | Yes |